Lv41
718 积分 2025-02-06 加入
Cis interactions between CD2 and its ligands on T cells are required for T cell activation
2小时前
待确认
Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
7天前
已完结
A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor–Resistant Lung Tumors
21天前
已完结
Regulators of CD8+ T cell exhaustion
27天前
已完结
Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies
28天前
已关闭
Ruxolitinib, a novel JAK/STAT-targeted therapy through restoring mucosal homeostasis for chronic rhinosinusitis with nasal polyps
1个月前
已完结
Dual Inhibition of Interleukin-23 and Interleukin-17 Offers Superior Efficacy in Mouse Models of Autoimmunity
1个月前
已完结
P0640 Development and characterization of LQ080, a novel extended half-life bispecific TL1A/IL-23 p19 single domain antibody for the treatment of IBD
1个月前
已完结
Anti-TL1A monoclonal antibody modulates the dysregulation of Th1/Th17 cells and attenuates granuloma formation in sarcoidosis by inhibiting the PI3K/AKT signaling pathway
1个月前
已完结
Anti-IL-4R-JAKi antibody-drug conjugate effectively reduces IgE levels and inflammatory cell infiltration in Atopic Dermatitis 9245
2个月前
已完结
皖公网安备34019202002308
